Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P08779 3868 KRT16 KRT16A Glioblastoma multiforme Phosphorylation N S10 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Phosphorylation N S10 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Methylation N K15 P08779 3868 KRT16 KRT16A Colon adenocarcinoma Phosphorylation N S28 P08779 3868 KRT16 KRT16A Colon adenocarcinoma Phosphorylation N S32 P08779 3868 KRT16 KRT16A Lung adenocarcinoma Phosphorylation N S44 P08779 3868 KRT16 KRT16A Lung adenocarcinoma Phosphorylation N S51 P08779 3868 KRT16 KRT16A Glioblastoma multiforme Phosphorylation N S130 P08779 3868 KRT16 KRT16A Keratoconus Phosphorylation N S130 P08779 3868 KRT16 KRT16A Pachyonychia congenita Phosphorylation N S130 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Phosphorylation N S130 P08779 3868 KRT16 KRT16A Glioblastoma multiforme Phosphorylation N Y131 P08779 3868 KRT16 KRT16A Keratoconus Phosphorylation N Y131 P08779 3868 KRT16 KRT16A Pachyonychia congenita Phosphorylation N Y131 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Phosphorylation N Y131 P08779 3868 KRT16 KRT16A Glioblastoma multiforme Acetylation N K134 P08779 3868 KRT16 KRT16A Pachyonychia congenita Acetylation N K134 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Acetylation N K134 P08779 3868 KRT16 KRT16A Glioblastoma multiforme Ubiquitination N K134 P08779 3868 KRT16 KRT16A Skin cutaneous melanoma Ubiquitination N K134 P08779 3868 KRT16 KRT16A Bladder urothelial carcinoma Phosphorylation N S165 P08779 3868 KRT16 KRT16A Lung adenocarcinoma Phosphorylation N T235 P08779 3868 KRT16 KRT16A Prostate adenocarcinoma Phosphorylation N T235 P08779 3868 KRT16 KRT16A Glioblastoma multiforme Phosphorylation N Y250 P08779 3868 KRT16 KRT16A Lung squamous cell carcinoma Phosphorylation N Y250 P08779 3868 KRT16 KRT16A Inborn genetic diseases Phosphorylation N Y293 P08779 3868 KRT16 KRT16A Stomach adenocarcinoma Phosphorylation N Y293 P08779 3868 KRT16 KRT16A Breast invasive carcinoma Ubiquitination N K317 P08779 3868 KRT16 KRT16A Breast invasive carcinoma Phosphorylation N S321 P08779 3868 KRT16 KRT16A Uterine corpus endometrial carcinoma Phosphorylation N S360 P08779 3868 KRT16 KRT16A Pachyonychia congenita Phosphorylation N T416 P08779 3868 KRT16 KRT16A Bladder urothelial carcinoma Phosphorylation N Y417 P08779 3868 KRT16 KRT16A Pachyonychia congenita Phosphorylation N Y417 P08779 3868 KRT16 KRT16A Leiomyosarcoma Phosphorylation N S449 P08779 3868 KRT16 KRT16A Lung squamous cell carcinoma Phosphorylation N S449 P08779 3868 KRT16 KRT16A Sarcoma Phosphorylation N S449 P08779 3868 KRT16 KRT16A Leiomyosarcoma Methylation N K460 P08779 3868 KRT16 KRT16A Lung squamous cell carcinoma Methylation N K460 P08779 3868 KRT16 KRT16A Sarcoma Methylation N K460 P08779 3868 KRT16 KRT16A Stomach adenocarcinoma Methylation N K460 P29033 2706 GJB2 Deafness Acetylation N K15 P29033 2706 GJB2 Esophageal adenocarcinoma Acetylation N K15 P29033 2706 GJB2 Keratitis-ichthyosis-deafness syndrome Acetylation N K15 P29033 2706 GJB2 Lung squamous cell carcinoma Acetylation N K15 P29033 2706 GJB2 Deafness Methylation N R75 P29033 2706 GJB2 Hearing loss Methylation N R75 P29033 2706 GJB2 Hereditary palmoplantar keratoderma Methylation N R75 P29033 2706 GJB2 Keratoconus Methylation N R75 P29033 2706 GJB2 Palmoplantar keratoderma-deafness syndrome Methylation N R75 P29033 2706 GJB2 Deafness Acetylation N K102 P29033 2706 GJB2 Deafness Acetylation N K103 P29033 2706 GJB2 Deafness Acetylation N K108 P29033 2706 GJB2 Deafness Ubiquitination N K108 P29033 2706 GJB2 Deafness Acetylation N K112 P29033 2706 GJB2 Deafness Ubiquitination N K112 P29033 2706 GJB2 Deafness Acetylation N K116 P29033 2706 GJB2 Hearing impairment Acetylation N K116 P29033 2706 GJB2 Deafness Ubiquitination N K116 P29033 2706 GJB2 Hearing impairment Ubiquitination N K116 P29033 2706 GJB2 Deafness SUMOylation N K122 P29033 2706 GJB2 Hearing impairment SUMOylation N K122 P29033 2706 GJB2 Prostate adenocarcinoma SUMOylation N K122 P29033 2706 GJB2 Sarcoma SUMOylation N K122 P29033 2706 GJB2 Deafness Ubiquitination N K122 P29033 2706 GJB2 Hearing impairment Ubiquitination N K122 P29033 2706 GJB2 Prostate adenocarcinoma Ubiquitination N K122 P29033 2706 GJB2 Sarcoma Ubiquitination N K122 P29033 2706 GJB2 Deafness Phosphorylation N T123 P29033 2706 GJB2 Hearing impairment Phosphorylation N T123 P29033 2706 GJB2 Prostate adenocarcinoma Phosphorylation N T123 P29033 2706 GJB2 Sarcoma Phosphorylation N T123 P29033 2706 GJB2 Deafness Acetylation N K125 P29033 2706 GJB2 Vohwinkel syndrome Acetylation N K125 P29033 2706 GJB2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T177 P29033 2706 GJB2 Deafness Phosphorylation N T177 P29033 2706 GJB2 Lung adenocarcinoma Phosphorylation N T177 P29033 2706 GJB2 Medulloblastoma Phosphorylation N T177 P29033 2706 GJB2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation C S183 P29033 2706 GJB2 Deafness Phosphorylation N S183 P29033 2706 GJB2 Hearing loss Phosphorylation N S183 P29033 2706 GJB2 Lung adenocarcinoma Phosphorylation N S183 P29033 2706 GJB2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T186 P29033 2706 GJB2 Deafness Phosphorylation N T186 P29033 2706 GJB2 Hearing loss Phosphorylation N T186 P55064 362 AQP5 Bladder urothelial carcinoma Phosphorylation N S183 P55064 362 AQP5 Keratoconus Phosphorylation N S183 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Esophageal carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Lung squamous cell carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Ubiquitination N K44 Q16236 4780 NFE2L2 NRF2 Hepatocellular carcinoma Ubiquitination N K64 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Ubiquitination N K64 Q16236 4780 NFE2L2 NRF2 Stomach adenocarcinoma Phosphorylation N S215 Q16236 4780 NFE2L2 NRF2 Kidney renal papillary cell carcinoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S347 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S347 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S351 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S351 Q16236 4780 NFE2L2 NRF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S374 Q16236 4780 NFE2L2 NRF2 Lung squamous cell carcinoma Phosphorylation N S374 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Phosphorylation N S408 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Acetylation N K443 Q16236 4780 NFE2L2 NRF2 Stomach adenocarcinoma Acetylation N K445 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Acetylation N K445 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Acetylation N K462 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Ubiquitination N K462 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K506 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K508 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K516 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K518 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K518 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma SUMOylation N K518 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma SUMOylation N K518 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K533 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K533 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K536 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K536 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K538 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K538 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Acetylation N K555 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Acetylation N K555 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Ubiquitination N K574 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Ubiquitination N K574 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Phosphorylation N Y576 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N Y576 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Phosphorylation N S577 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S577 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K596 Q16236 4780 NFE2L2 NRF2 Breast adenocarcinoma Acetylation N K596 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K599 Q16236 4780 NFE2L2 NRF2 Breast adenocarcinoma Acetylation N K599 Q9NZR4 30813 VSX1 RINX Keratoconus Phosphorylation N S22 Q9NZR4 30813 VSX1 RINX Keratoconus Phosphorylation N S156 Q16236 4780 NFE2L2 NRF2 Esophageal squamous cell carcinoma tumor tissue Phosphorylation P 33390848 Q16236 4780 NFE2L2 NRF2 Cervical cancer tumor tissue Deubiquitination U 36527747 Q16236 4780 NFE2L2 NRF2 Clear cell renal cell carcinoma ccRCC tissue Ubiquitination D 32128917 Q16236 4780 NFE2L2 NRF2 Gastric cancer tumor tissue Ubiquitination D 32605589 Q16236 4780 NFE2L2 NRF2 Liver ischemia/reperfusion injury hepatocytes Threonine phosphorylation U T369 35108418 Q16236 4780 NFE2L2 NRF2 Colon cancer colon tumor tissues Acetylation U K438 36442525 Q16236 4780 NFE2L2 NRF2 Melanoma melanoma cells Glutarylation D 36050469 Q16236 4780 NFE2L2 NRF2 Clear cell renal cell carcinoma ccRCC tissues Phosphorylation U 32128917 P29033 2706 GJB2 Palmoplantar keratoderma Arginine methylation N R75 19775242 Q16236 4780 NFE2L2 NRF2 Keratoconus Serine phosphorylation D S40 36240204 Q16236 4780 NFE2L2 NRF2 Kaposi's sarcoma Serine phosphorylation U S40 25505069;25340789 Q16236 4780 NFE2L2 NRF2 Hepatocellular carcinoma SUMOylation P K110 31546024